Stock listing

NASDAQ:JUNS Jupiter Neurosciences, Inc. Stock

Home listing (NASDAQ) of Jupiter Neurosciences, Inc.

Follow Jupiter Neurosciences, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:JUNS

$1.24 USD -0.28 (-18.7%)

Close on Nov 20, 2026

Past year -98.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.20 – $1.46 USDNov 20, 2026
Volume
20,106 sharesNov 20, 2026
Market cap
$1.63M USDAt the close on Nov 20, 2026 · price × 1.32M shares outstanding
52-week range
$1.20 – $97.74 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$5.25M USDMedian day 23,593 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Jupiter Neurosciences, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:JUNS · Home$1.235 USD-0.285 (-18.7%)20,106$1.46$1.46$1.20$1.52Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:JUNS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.235-0.285-18.7%$1.46$1.46$1.2020,106
$1.520.000.0%$1.45$1.55$1.3714,933
$1.52-0.18-10.6%$1.625$1.65$1.47411,211
$1.70-0.06-3.4%$1.82$1.82$1.6311,772
$1.76-0.10-5.4%$1.86$1.885$1.7612,532
$1.86-0.28-13.1%$2.13$2.34$1.78544,027
$2.14-0.08-3.6%$2.20$2.20$2.148,837
$2.22+0.02+0.9%$2.29$2.29$2.157,816
$2.200.000.0%$2.208$2.295$2.1946,730
$2.20+0.07+3.3%$2.10$2.27$2.0124,714
$2.13-0.33-13.4%$2.36$2.36$2.08223,593
$2.46+0.03+1.2%$2.44$2.50$2.2419,723
$2.43+0.12+5.2%$2.37$2.47$2.277,415
$2.31+0.26+12.7%$2.11$2.43$2.1031,644
$2.05-0.32-13.5%$2.40$2.41$2.0517,256
$2.37-0.13-5.2%$2.56$2.56$2.367,172
$2.50-0.14-5.3%$2.62$2.70$2.4029,722
$2.64-0.22-7.7%$2.86$2.91$2.6441,541
$2.86-0.12-4.0%$3.00$3.01$2.71712,669
$2.98+0.40+15.5%$2.58$3.09$2.5819,625
$2.58-0.20-7.2%$2.76$2.76$2.55110,140
$2.78-0.02-0.7%$2.75$2.80$2.63128,572
$2.80+0.05+1.8%$2.75$3.24$2.7510,408
$2.75-0.155-5.3%$2.77$2.82$2.758,488
$2.905-0.235-7.5%$3.09$3.115$2.88113,924
$3.14-0.05-1.6%$3.16$3.27$3.02519,811
$3.19-0.17-5.1%$3.30$3.43$3.0720,925
$3.36+0.32+10.5%$3.00$3.50$3.0071,300
$3.04+0.19+6.7%$2.89$3.04$2.7637,200
$2.85+0.08+2.9%$2.83$2.89$2.677,000
$2.77-0.07-2.5%$2.70$2.85$2.6636,800
$2.84-0.02-0.7%$2.61$2.858$2.5847,100
$2.86+0.44+18.2%$2.38$3.18$2.251924,100
$2.42-0.13-5.1%$2.425$2.55$2.3314,900
$2.55+0.05+2.0%$2.50$2.60$2.5011,600
$2.50+0.06+2.5%$2.57$2.57$2.3913,300
$2.44-0.14-5.4%$2.51$2.61$2.3516,800
$2.58+0.07+2.8%$2.54$2.60$2.3814,900
$2.51-0.16-6.0%$2.67$2.67$2.4053,000
$2.67-0.215-7.5%$2.82$2.966$2.6758,900
$2.885-0.085-2.9%$3.06$3.06$2.8036,800
$2.97-0.01-0.3%$2.97$3.00$2.90237,200
$2.98+0.11+3.8%$2.90$3.68$2.86455,700
$2.87+0.01+0.3%$2.956$2.965$2.8617,100
$2.86-0.15-5.0%$3.05$3.14$2.8617,600
$3.01+0.08+2.7%$2.97$3.06$2.9610,900
$2.93-0.08-2.7%$3.02$3.19$2.8822,000
$3.01-0.40-11.7%$3.45$3.45$3.0057,800
$3.41+0.36+11.8%$3.12$3.557$3.0673,000
$3.05-0.10-3.2%$3.17$3.20$3.0021,000
$3.15+0.06+1.9%$3.05$3.406$3.0541,700
$3.09+0.01+0.3%$3.06$3.238$2.9429,500
$3.08-0.20-6.1%$3.20$3.28$3.0641,000
$3.28+0.02+0.6%$3.36$3.609$3.2725,000
$3.26-0.17-5.0%$3.46$3.49$3.2620,600
$3.43+0.08+2.4%$3.35$3.52$3.2735,000
$3.35-0.19-5.4%$3.39$3.57$3.2259,200
$3.54-0.64-15.3%$3.00$3.65$2.88258,200
$4.18-0.71-14.5%$5.15$5.15$4.101254,800
$4.89-0.12-2.4%$4.94$5.00$4.71186,800
$5.01-0.16-3.1%$4.67$5.40$4.621222,700
$5.17-0.49-8.7%$5.58$5.692$4.93228,518
$5.66-0.54-8.7%$5.65$6.00$5.42632,861
$6.20+1.03+19.9%$8.25$11.20$5.5052,405,500
$5.17+0.37+7.7%$4.80$5.23$4.8036,000

Splits

1 split · NASDAQ:JUNS · every price before a split is adjusted for it

DayRatioWhat
1-for-75Consolidation
Ticker
NASDAQ:JUNS
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Jupiter Neurosciences, Inc. news

Jupiter Neurosciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
22 in the last 12 months · 42 in all · newest Oct 6, 2026 · oldest 2025
Decks
3 decks · latest Apr 2, 2026

Where Jupiter Neurosciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:JUNS · Home listing · This pageNASDAQUnited StatesUSD
BOATS:JUNSBOATSUnited StatesUSD

Valuation

EV/sales 16.9× against a median of 5.5×: 4th lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.33M USD
P/E
Loss
EV/sales
16.9×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
Revenue too small
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
Negative equity
Beta vs S&P 500
1.88

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Jupiter Neurosciences, Inc. · NASDAQ:JUNSUS$1.63MUS$1.33Mn/a16.9×n/an/an/an/a1.88
Propanc Biopharma, Inc. · NASDAQ:PPCBUS$1.84MUS$1.62Mn/an/an/a0.3×n/a0.0×1.39
Argent Biopharma Ltd · ASX:RGTUS$1.79MUS$8.05Mn/a75.4×n/an/an/an/an/a
Calidi Biotherapeutics, Inc. · AMEX:CLDIUS$1.76M−US$2.19Mn/an/an/a1.1×n/a0.0×1.86
Kala Bio, Inc. · NASDAQ:KALAUS$1.74M−US$5.49Mn/an/an/a0.2×n/a0.0×2.76
SOHM, Inc. · OTC:SHMNUS$1.74MUS$4.99Mn/a5.5×n/a0.5×−28.1%0.9×-0.10
PRF Technologies Ltd. · NASDAQ:PRFXUS$1.66M−US$9.82Mn/a−249×n/a0.1×n/a0.0×1.93
Kairos Pharma, Ltd. · AMEX:KAPAUS$1.48M−US$1.65Mn/an/an/a0.4×n/a0.0×1.36
BioRestorative Therapies, Inc. · NASDAQ:BRTXUS$1.45M−US$2.11Mn/a−5.9×n/a0.5×n/a0.0×1.81
Nutra Pharma Corp. · OTC:NPHCUS$1.43MUS$13.99Mn/a87.0×n/an/an/an/an/a
Aptevo Therapeutics Inc. · NASDAQ:APVOUS$1.40M−US$2.88Mn/an/an/a0.4×n/a1.0×0.93
Median of the othersUS$1.70M−US$1.88M5.5×0.4×−28.1%0.0×1.60

Forecasts

Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.

Price target
30.00 USD · Analysts' mean
EPS, year to Dec 2025
-0.26 · 1 analyst

Team and board

Officers

OfficerRole
Christer RosénFounder, Chairman & CEO
Saleem ElmasriCFO
Alison D. SilvaPresident & CBO
Alexander RosénCo-Founder, CAO
Claes WahlestedtCo-Founder, Consulting CMO
Marshall HaywardCo-Founder, CSO
Shaun P BrothersCo-Founder, Consulting Head of Scientific Research

Board

DirectorRole
Christer RosénFounder, Chairman & CEO
Alison D. SilvaPresident & CBO
Holger Weis
Julie Kampf
Marshall HaywardCo-Founder, CSO
Nicholas Hemmerly

Events

QuarterResultsShare move
Q3 2026Nov 16, 2026−13.6%
Q2 2026Aug 14, 2026−13.7%
Q1 2026Jun 3, 2026−8.4%
Q4 2025Feb 25, 2026−5.0%
Q3 2025Nov 14, 2025 · After close−5.2%
Q2 2025Aug 18, 20250.0%
Q1 2025May 15, 2025 · After close−3.0%
Q4 2024Feb 26, 2025−2.3%
Q3 2024Dec 23, 2024 · After close+3.4%
Q4 2021Jan 5, 2022
All 11 quarters
QuarterResultsShare move
Q3 2021Nov 9, 2021

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (April 2026)Investor deck14 slidesApr 2, 2026
Investor Presentation (2025)Investor deck10 slidesDec 9, 2025
Investor Presentation (February 2025)Investor deck18 slidesFebruary 2025

Open Decks

Financings

RaiseDate
Convertible Promissory Notes
Terms changed: US$6M
Buyers: Yorkville Advisors Global, LP (affiliate) ($6 million pre-paid advance, $4 million funded at signing); YA II PN, Ltd.
Use of proceeds: Phase 2 Parkinson's trial of JOTROL, Nugevia direct-to-consumer marketing and sales growth, working capital and general corporate purposes
Feb 23, 2026
Common stock under standby equity purchase agreement
Announced: up to US$14M
Buyers: Yorkville Advisors Global, LP (affiliate) (up to $14 million of Common Stock over 24 months)
Use of proceeds: Phase 2 Parkinson's trial of JOTROL, Nugevia direct-to-consumer marketing and sales growth, working capital and general corporate purposes
Oct 27, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$4.00 a share on Dec 2, 2024.

Price
US$4.00 a share
Shares offered
2,750,000 shares of common stock
Offering size
US$11 million
Listing
JUNS on the Nasdaq Capital Market
Shares delivered
On or about Dec 4, 2024

Steps

StepWhen
Draft sent to the SEC in confidenceOct 1, 2021
Filed publiclyOct 12, 2021
Amended 22 timesNewest Oct 18, 2024
Shares registered with an exchangeFeb 4, 2022
Declared effective by the SECNov 8, 2024
Final prospectus, with the priceDec 2, 2024

Filings

FilingFiled
424B3 · ProspectusDec 2, 2024
424B4 · ProspectusDec 2, 2024
CERT · Exchange's certificate of listingDec 2, 2024
EFFECT · Notice that a registration is effectiveNov 8, 2024
CORRESP · Letter to the SECNov 7, 2024
CORRESP · Letter to the SECNov 7, 2024
S-1/A · Registration statement, amendedOct 18, 2024
S-1/A · Registration statement, amendedSep 13, 2024
CORRESP · Letter to the SECSep 13, 2024
UPLOAD · Letter from the SECSep 12, 2024
All 81 filings
FilingFiled
S-1/A · Registration statement, amendedSep 4, 2024
CORRESP · Letter to the SECSep 4, 2024
S-1/A · Registration statement, amendedSep 4, 2024
CORRESP · Letter to the SECSep 3, 2024
UPLOAD · Letter from the SECAug 7, 2024
S-1/A · Registration statement, amendedJul 12, 2024
UPLOAD · Letter from the SECFeb 2, 2024
CORRESP · Letter to the SECFeb 15, 2023
CORRESP · Letter to the SECFeb 15, 2023
CORRESP · Letter to the SECFeb 9, 2023
CORRESP · Letter to the SECFeb 9, 2023
CORRESP · Letter to the SECJan 17, 2023
S-1/A · Registration statement, amendedJan 17, 2023
UPLOAD · Letter from the SECJan 13, 2023
S-1/A · Registration statement, amendedJan 6, 2023
CORRESP · Letter to the SECDec 7, 2022
S-1/A · Registration statement, amendedDec 7, 2022
UPLOAD · Letter from the SECDec 6, 2022
S-1/A · Registration statement, amendedDec 2, 2022
CORRESP · Letter to the SECSep 20, 2022
CORRESP · Letter to the SECSep 20, 2022
CORRESP · Letter to the SECSep 16, 2022
CORRESP · Letter to the SECSep 16, 2022
CORRESP · Letter to the SECSep 13, 2022
CORRESP · Letter to the SECSep 13, 2022
CORRESP · Letter to the SECSep 12, 2022
CORRESP · Letter to the SECSep 12, 2022
CORRESP · Letter to the SECAug 26, 2022
S-1/A · Registration statement, amendedAug 26, 2022
UPLOAD · Letter from the SECAug 25, 2022
8-A12B/A · Registration of shares for listing on an exchange, amendedAug 24, 2022
S-1/A · Registration statement, amendedAug 16, 2022
S-1/A · Registration statement, amendedMay 18, 2022
CORRESP · Letter to the SECMay 5, 2022
S-1/A · Registration statement, amendedMay 5, 2022
UPLOAD · Letter from the SECMay 4, 2022
CORRESP · Letter to the SECMay 4, 2022
S-1/A · Registration statement, amendedMay 4, 2022
UPLOAD · Letter from the SECMay 3, 2022
S-1/A · Registration statement, amendedApr 26, 2022
CORRESP · Letter to the SECFeb 14, 2022
CORRESP · Letter to the SECFeb 14, 2022
CORRESP · Letter to the SECFeb 10, 2022
CORRESP · Letter to the SECFeb 10, 2022
CORRESP · Letter to the SECFeb 10, 2022
CORRESP · Letter to the SECFeb 10, 2022
CORRESP · Letter to the SECFeb 8, 2022
CORRESP · Letter to the SECFeb 8, 2022
CORRESP · Letter to the SECFeb 8, 2022
CORRESP · Letter to the SECFeb 8, 2022
CERT · Exchange's certificate of listingFeb 4, 2022
8-A12B · Registration of shares for listing on an exchangeFeb 4, 2022
CORRESP · Letter to the SECFeb 3, 2022
CORRESP · Letter to the SECFeb 3, 2022
S-1/A · Registration statement, amendedFeb 3, 2022
S-1/A · Registration statement, amendedFeb 3, 2022
CORRESP · Letter to the SECFeb 2, 2022
UPLOAD · Letter from the SECJan 31, 2022
S-1/A · Registration statement, amendedJan 26, 2022
S-1/A · Registration statement, amendedJan 5, 2022
CORRESP · Letter to the SECDec 23, 2021
S-1/A · Registration statement, amendedDec 23, 2021
UPLOAD · Letter from the SECDec 22, 2021
CORRESP · Letter to the SECDec 17, 2021
S-1/A · Registration statement, amendedDec 17, 2021
UPLOAD · Letter from the SECNov 19, 2021
CORRESP · Letter to the SECNov 9, 2021
S-1/A · Registration statement, amendedNov 9, 2021
UPLOAD · Letter from the SECOct 28, 2021
S-1 · Registration statementOct 12, 2021
DRS · Draft registration statementOct 1, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Dec 2, 2024

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue21.8K00233.3K638.0K1.13M
Cost of revenue4.23K
Gross profit17.6K233.3K638.0K1.13M
Research and development2.09M492.7K954.8K942.8K1.45M1.64M685.7K
Selling, general and administrative6.84M2.60M2.92M2.72M3.10M1.34M1.49M
Operating income-8.91M-3.09M-3.87M-3.43M-3.91M-1.85M-2.18M
Depreciation and amortization43.3K694.2K784.3K179.2K210.4K553.0K
EBITDA-3.05M-3.18M-2.65M-3.73M-1.64M-1.62M
Interest expense66.0K248.4K218.7K740.9K114.0K13.5K317.1K
Income before tax-8.64M-2.44M-4.78M-4.96M-4.20M-1.65M-3.05M
Income tax179.2K
Net income-8.64M-2.44M-4.78M-4.96M-4.38M-1.65M-3.05M
Earnings per share, basic-0.25-0.08-0.18-11.31-34.62-14.20-26.15
Earnings per share, diluted-0.25-0.08-0.18

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents3.79M3.77M28.5K64.4K330.6K208.0K1.28K
Receivables2.64K0126.2K
Inventory159.8K0
Current assets4.82M4.65M28.7K69.7K454.7K550.0K4.97K
Total assets5.56M6.20M148.6K235.9K667.4K550.0K6.18K
Accounts payable131.1K278.7K189.5K187.0K256.9K252.2K131.1K
Current liabilities7.40M2.01M5.77M7.26M5.68M4.26M5.02M
Long-term debt106.7K
Total debt5.32M217.8K2.25M1.90M651.2K108.5K1.21M
Total liabilities7.40M2.03M5.95M7.38M5.85M4.26M5.02M
Shareholders' equity-1.83M4.17M-5.80M-7.14M-5.18M-3.71M-5.02M
Shares outstanding459.3K33.1M26.5M438.4K126.5K116.5K116.5K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-5.41M-3.91M-481.0K-1.25M-1.74M-254.8K-143.0K
Capital spending-4-4-3-4-400
Free cash flow-5.41M-3.91M-481.0K-1.25M-1.74M-254.8K-143.0K
Cash from financing5.43M7.65M445.0K982.3K1.86M461.5K107.8K
Change in cash19.8K3.74M-36.0K-266.2K122.6K206.7K-35.2K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 16, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 26, 2026Big-stake noticeSEC
S-8 · Registration statement for employee plansOct 9, 2026Offer documentSEC
S-3 · Registration statementSep 24, 2026Offer documentSEC
SCHEDULE 13G · Big-stake noticeSep 22, 2026Big-stake noticeSEC
DSep 4, 2026Other filingsSEC
8-K · Current reportSep 3, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 28, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 28, 2026Big-stake noticeSEC
8-K · Current reportAug 28, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportAug 27, 2026Material contractSEC
8-K · Current reportAug 24, 2026Current reportSEC
8-K · Current reportAug 24, 2026Material contractSEC
424B5 · ProspectusAug 24, 2026Offer documentSEC
10-Q · Quarterly reportAug 14, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026Current reportSEC
4 · Change in ownershipAug 5, 2026Insider tradeSEC
424B3 · ProspectusJul 29, 2026Offer documentSEC
8-K · Current reportJul 28, 2026FinancingSEC
424B3 · ProspectusJul 27, 2026Offer documentSEC
8-K · Current reportJul 27, 2026Meeting outcomeSEC
3 · Initial statement of ownershipJul 22, 2026Insider tradeSEC
424B3 · ProspectusJul 21, 2026Offer documentSEC
8-K · Current reportJul 21, 2026Material contractSEC
4 · Change in ownershipJul 13, 2026Insider tradeSEC
4 · Change in ownershipJul 13, 2026Insider tradeSEC
4 · Change in ownershipJul 13, 2026Insider tradeSEC
4 · Change in ownershipJul 13, 2026Insider tradeSEC
4 · Change in ownershipJul 13, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveJul 8, 2026Other filingsSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
3 · Initial statement of ownershipJul 1, 2026Insider tradeSEC
424B3 · ProspectusJun 30, 2026Offer documentSEC
8-K · Current reportJun 30, 2026Management or board changeSEC
S-1 · Registration statementJun 26, 2026Offer documentSEC
ARS · Annual report to shareholdersJun 22, 2026Annual reportSEC
DEF 14A · Proxy statementJun 22, 2026Meeting noticeSEC
424B3 · ProspectusJun 22, 2026Offer documentSEC
8-K · Current reportJun 22, 2026Management or board changeSEC
PRE 14A · Preliminary proxy statementJun 9, 2026Meeting noticeSEC
424B3 · ProspectusJun 5, 2026Offer documentSEC
8-K · Current reportJun 5, 2026Management or board changeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
424B3 · ProspectusMay 21, 2026Offer documentSEC
424B3 · ProspectusMay 21, 2026Offer documentSEC
8-K · Current reportMay 21, 2026Material contractSEC
424B5 · ProspectusMay 21, 2026Offer documentSEC
424B3 · ProspectusMay 20, 2026Offer documentSEC
8-K · Current reportMay 20, 2026Current reportSEC
424B3 · ProspectusMay 14, 2026Offer documentSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
424B3 · ProspectusMay 8, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveApr 27, 2026Other filingsSEC
CORRESP · Letter to the SECApr 22, 2026Other filingsSEC
UPLOAD · Letter from the SECApr 22, 2026Other filingsSEC
S-3 · Registration statementApr 15, 2026Offer documentSEC
10-K · Annual reportApr 1, 2026Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2026Explanation requestSEC
8-K · Current reportFeb 27, 2026Current reportSEC
8-K · Current reportFeb 20, 2026Material contractSEC
S-8 · Registration statement for employee plansFeb 13, 2026Offer documentSEC
8-K · Current reportDec 23, 2025Material contractSEC
8-K · Current reportDec 22, 2025Management or board changeSEC
424B3 · ProspectusDec 19, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveDec 12, 2025Other filingsSEC
CORRESP · Letter to the SECDec 9, 2025Other filingsSEC
S-1 · Registration statementNov 26, 2025Offer documentSEC
8-K/A · Current report, amendedNov 20, 2025Material contractSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
DEFA14A · Additional proxy materialNov 7, 2025Meeting noticeSEC
ARS · Annual report to shareholdersNov 6, 2025Annual reportSEC
DEFA14A · Additional proxy materialNov 6, 2025Meeting noticeSEC
DEF 14A · Proxy statementNov 6, 2025Meeting noticeSEC
PRER14AOct 27, 2025Other filingsSEC
8-K · Current reportOct 27, 2025Material contractSEC
PRE 14A · Preliminary proxy statementOct 17, 2025Meeting noticeSEC
10-Q · Quarterly reportAug 18, 2025Quarterly reportSEC
NT 10-Q · Late filing noticeAug 14, 2025Explanation requestSEC
8-K · Current reportJul 10, 2025Current reportSEC
8-K · Current reportJul 9, 2025Management or board changeSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
4 · Change in ownershipJul 3, 2025Insider tradeSEC
4 · Change in ownershipJul 3, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
10-Q · Quarterly reportMay 15, 2025Quarterly reportSEC
8-K · Current reportApr 21, 2025Current reportSEC
10-K · Annual reportMar 28, 2025Annual reportSEC
8-K · Current reportMar 25, 2025Current reportSEC
4 · Change in ownershipJan 24, 2025Insider tradeSEC
4 · Change in ownershipJan 24, 2025Insider tradeSEC
10-Q · Quarterly reportDec 23, 2024Quarterly reportSEC
8-K · Current reportDec 20, 2024Management or board changeSEC
8-K · Current reportDec 19, 2024Material contractSEC
8-K · Current reportDec 4, 2024Material contractSEC
424B3 · ProspectusDec 2, 2024Offer documentSEC
424B4 · ProspectusDec 2, 2024Offer documentSEC
CERT · Exchange's certificate of listingDec 2, 2024Other filingsSEC
8-K · Current reportNov 19, 2024Material contractSEC
SC 13D · Big-stake noticeNov 15, 2024Big-stake noticeSEC
SC 13D · Big-stake noticeNov 15, 2024Big-stake noticeSEC
SC 13D · Big-stake noticeNov 15, 2024Big-stake noticeSEC
SC 13D · Big-stake noticeNov 15, 2024Big-stake noticeSEC
SC 13D · Big-stake noticeNov 15, 2024Big-stake noticeSEC
3 · Initial statement of ownershipNov 13, 2024Insider tradeSEC
EFFECT · Notice that a registration is effectiveNov 12, 2024Other filingsSEC
3 · Initial statement of ownershipNov 8, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 8, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 8, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 8, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 8, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 8, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 8, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 8, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 8, 2024Insider tradeSEC
CORRESP · Letter to the SECNov 7, 2024Other filingsSEC
CORRESP · Letter to the SECNov 7, 2024Other filingsSEC
S-1/A · Registration statement, amendedOct 18, 2024Offer documentSEC
S-1/A · Registration statement, amendedSep 13, 2024Offer documentSEC
CORRESP · Letter to the SECSep 13, 2024Other filingsSEC
UPLOAD · Letter from the SECSep 12, 2024Other filingsSEC
S-1/A · Registration statement, amendedSep 4, 2024Offer documentSEC
CORRESP · Letter to the SECSep 4, 2024Other filingsSEC
CORRESP · Letter to the SECSep 3, 2024Other filingsSEC
S-1/A · Registration statement, amendedSep 3, 2024Offer documentSEC
UPLOAD · Letter from the SECAug 7, 2024Other filingsSEC
S-1/A · Registration statement, amendedJul 12, 2024Offer documentSEC
UPLOAD · Letter from the SECFeb 2, 2024Other filingsSEC
CORRESP · Letter to the SECFeb 15, 2023Other filingsSEC
CORRESP · Letter to the SECFeb 15, 2023Other filingsSEC
CORRESP · Letter to the SECFeb 9, 2023Other filingsSEC
CORRESP · Letter to the SECFeb 9, 2023Other filingsSEC
CORRESP · Letter to the SECJan 17, 2023Other filingsSEC
S-1/A · Registration statement, amendedJan 17, 2023Offer documentSEC
UPLOAD · Letter from the SECJan 13, 2023Other filingsSEC
S-1/A · Registration statement, amendedJan 6, 2023Offer documentSEC
CORRESP · Letter to the SECDec 7, 2022Other filingsSEC
S-1/A · Registration statement, amendedDec 7, 2022Offer documentSEC
UPLOAD · Letter from the SECDec 6, 2022Other filingsSEC
S-1/A · Registration statement, amendedDec 2, 2022Offer documentSEC
CORRESP · Letter to the SECSep 20, 2022Other filingsSEC
CORRESP · Letter to the SECSep 20, 2022Other filingsSEC
CORRESP · Letter to the SECSep 16, 2022Other filingsSEC
CORRESP · Letter to the SECSep 16, 2022Other filingsSEC
CORRESP · Letter to the SECSep 13, 2022Other filingsSEC
CORRESP · Letter to the SECSep 13, 2022Other filingsSEC
CORRESP · Letter to the SECSep 12, 2022Other filingsSEC
CORRESP · Letter to the SECSep 12, 2022Other filingsSEC
CORRESP · Letter to the SECAug 26, 2022Other filingsSEC
S-1/A · Registration statement, amendedAug 26, 2022Offer documentSEC
UPLOAD · Letter from the SECAug 25, 2022Other filingsSEC
8-A12B/A · Registration of shares for listing on an exchange, amendedAug 24, 2022Other filingsSEC
S-1/A · Registration statement, amendedAug 16, 2022Offer documentSEC
S-1/A · Registration statement, amendedMay 18, 2022Offer documentSEC
CORRESP · Letter to the SECMay 5, 2022Other filingsSEC
S-1/A · Registration statement, amendedMay 5, 2022Offer documentSEC
UPLOAD · Letter from the SECMay 4, 2022Other filingsSEC
CORRESP · Letter to the SECMay 4, 2022Other filingsSEC
S-1/A · Registration statement, amendedMay 4, 2022Offer documentSEC
UPLOAD · Letter from the SECMay 3, 2022Other filingsSEC
S-1/A · Registration statement, amendedApr 25, 2022Offer documentSEC
CORRESP · Letter to the SECFeb 14, 2022Other filingsSEC
CORRESP · Letter to the SECFeb 14, 2022Other filingsSEC
CORRESP · Letter to the SECFeb 10, 2022Other filingsSEC
CORRESP · Letter to the SECFeb 10, 2022Other filingsSEC
CORRESP · Letter to the SECFeb 10, 2022Other filingsSEC
CORRESP · Letter to the SECFeb 10, 2022Other filingsSEC
CORRESP · Letter to the SECFeb 8, 2022Other filingsSEC
CORRESP · Letter to the SECFeb 8, 2022Other filingsSEC
CORRESP · Letter to the SECFeb 8, 2022Other filingsSEC
CORRESP · Letter to the SECFeb 8, 2022Other filingsSEC
CERT · Exchange's certificate of listingFeb 4, 2022Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeFeb 4, 2022Other filingsSEC
CORRESP · Letter to the SECFeb 3, 2022Other filingsSEC
CORRESP · Letter to the SECFeb 3, 2022Other filingsSEC
S-1/A · Registration statement, amendedFeb 3, 2022Offer documentSEC
CORRESP · Letter to the SECFeb 2, 2022Other filingsSEC
S-1/A · Registration statement, amendedFeb 2, 2022Offer documentSEC
UPLOAD · Letter from the SECJan 31, 2022Other filingsSEC
S-1/A · Registration statement, amendedJan 26, 2022Offer documentSEC
S-1/A · Registration statement, amendedJan 5, 2022Offer documentSEC
CORRESP · Letter to the SECDec 23, 2021Other filingsSEC
S-1/A · Registration statement, amendedDec 23, 2021Offer documentSEC
UPLOAD · Letter from the SECDec 22, 2021Other filingsSEC
CORRESP · Letter to the SECDec 17, 2021Other filingsSEC
S-1/A · Registration statement, amendedDec 17, 2021Offer documentSEC
UPLOAD · Letter from the SECNov 19, 2021Other filingsSEC
CORRESP · Letter to the SECNov 9, 2021Other filingsSEC
S-1/A · Registration statement, amendedNov 9, 2021Offer documentSEC
UPLOAD · Letter from the SECOct 28, 2021Other filingsSEC
S-1 · Registration statementOct 12, 2021Offer documentSEC

This page holds 200 of 204 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Jupiter Neurosciences, Inc.’s releases · as of Nov 16, 2026

Common shares
1,318,521
Fully diluted
1,318,521

Fully diluted

LineSharesAs of
Common shares1,318,521Nov 16, 2026

Share count over time

CountShares
Nov 16, 20261,318,521
Aug 5, 2026

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vestor Capital, LLC14,0091.1%US$3,985Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund128K9.7%US$27,427Jun 30, 2026
Fidelity Extended Market Index Fund124K9.4%US$31,869May 31, 2026
Fidelity Series Total Market Index Fund17,9791.4%US$4,603May 31, 2026
Fidelity Total Market Index Fund16,0751.2%US$4,115May 31, 2026
Fidelity Nasdaq Composite Index Fund15,8601.2%US$4,060May 31, 2026

Big stakes

StakeStakeSharesDateFiling
PharmAla Biotech Holdings Inc.10.10%133KSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Holger Weis
Other companies: Alaunos Therapeutics, Inc. (Chairman and Chief Executive Officer · Since at least Apr 13, 2025)
Director · Since at least Jun 2, 2025
Nicholas Hemmerly
Other companies: Liberty Star Uranium & Metals Corp. (Director · Since at least Sep 26, 2022)
Director · Since at least Nov 8, 2024
Saleem Elmasri
Other companies: Liberty Star Uranium & Metals Corp. (Director · Since at least Aug 14, 2023)
CFO · Since at least Nov 8, 2024
Alexander RosénCo-Founder, CAO · Since at least Jul 13, 2026
Alison D. SilvaPresident and COO, Director · Since at least Jun 2, 2025
Allison W BradyDirector · Since at least Nov 8, 2024
Christer RosénFounder, Chairman & CEO · Since at least Oct 6, 2026
Claes WahlestedtCo-Founder, Consulting CMO · Since at least Nov 5, 2026
Julie KampfDirector · Since at least Jun 2, 2025
Marshall HaywardCo-Founder, CSO · Since at least Jun 2, 2025
All 11 people
PersonSeat
Shaun P BrothersCo-Founder, Consulting Head of Scientific Research · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Jupiter Neurosciences, Inc.